SCHEMBL7548014

SCHEMBL7548014

N#CC1CCN(CCn2cc(-c3cncc(-c4ccccc4)c3)c3ncccc32)CC1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDR P35968 6/20 0.43
FLT1 P17948 3/20 0.42
FLT4 P35916 3/20 0.42
LTA4H P09960 2/20 0.37
GSK3B P49841 2/20 0.37
CHRNB1 P11230 1/20 0.34
CHRNB2 P17787 1/20 0.34
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
CHRNB3 Q05901 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34
USP30 Q70CQ3 1/20 0.33
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
CHEK1 O14757 1/20 0.33
ACHE P22303 1/20 0.33
GRIN1 Q05586 2/20 0.32
GRIN2B Q13224 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7553729 0.92 KDR (0.40) KDRFLT1FLT4LTA4HGSK3B
SCHEMBL7553655 0.90 KDR (0.39) KDRFLT1FLT4GSK3BGRIN1
SCHEMBL7551721 0.90 CHRNB1 (0.39) KDRFLT1FLT4LTA4HGSK3B
SCHEMBL7557708 0.89 KDR (0.56) KDRFLT1FLT4GSK3BDRD2
SCHEMBL7549687 0.88 AVPR1B (0.38) KDRFLT1FLT4CHRNB1CHRNB2
SCHEMBL7549926 0.87 KDR (0.57) KDRFLT1FLT4GSK3BEGLN1
SCHEMBL7548593 0.85 KDR (0.57) KDRFLT1FLT4LTA4HGSK3B
SCHEMBL7987209 0.84 KDR (0.58) KDRFLT1FLT4GSK3B
SCHEMBL7550735 0.83 KDR (0.42) KDRFLT1FLT4LTA4HCHRNB1
SCHEMBL7509366 0.81 KDR (0.47) KDRFLT1FLT4LTA4HGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed